Table 3.
Reduction percentage in the wound dimensions after 40 days (T3) and at the end of treatment period with respect to T0 (Wilcoxon test). Scores: 5: wound reduced by 100%; 4: wound in healing phase, reduction <100%; 3: wound clearly improved, reduction of 70 ± 5%; 2: wound improved, reduction of 50 ± 5%; 1: slightly improved, reduction of 30 ± 5%; 0: unchanged, with no reduction
| Variation in the wound dimensions (%) | Keratinocytes [n (%)] | Fibroblasts [n (%)] | Overall [n (%)] |
|---|---|---|---|
| Score at T3 | |||
| 5 | 5 (38·46%) | – | 5 (16·67%) |
| 4 | – | 3 (17·65%) | 3 (10·00%) |
| 3 | 5 (30·77%) | 9 (52·94%) | 14 (46·67%) |
| 2 | 1 (7·69%) | 4 (23·53%) | 5 (16·67%) |
| 1 | 2 (15·38%) | 1 (5·88%) | 3 (10·00%) |
| 0 | – | – | – |
| Mean (n) ± SD | 3·39 ± 1·50 | 2·71 ± 0·77 | 3·00 ± 1·77 |
| Score at the end | |||
| 5 | 9 (69·23%) | 9 (52·94%) | 18 (60·00%) |
| 4 | 2 (15·38%) | 5 (29·41%) | 7 (23·33%) |
| 3 | – | 3 (17·65%) | 3 (10·00%) |
| 2 | 1 (7·69%) | – | 1 (3·33%) |
| 1 | 1 (7·69%) | – | 1 (3·33%) |
| 0 | – | – | – |
| Mean (n) ± SD | 4·31 ± 1·32 | 4·23 ± 1·03 | 4·27 ± 1·14 |